[Clinical trials of the combination: orthoxyquinoline sulfonate of aminophenazone-vitamin B 6- vitamin B 12 (Liocausyth) in rheumatological and neuritic diseases].
D000328:Adult; D000368:Aged; D000632:Aminopyrine / Q000627:therapeutic use*; D000700:Analgesics / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D009437:Neuralgia / Q000188:drug therapy*; D009443:Neuritis / Q000188:drug therapy*; D010146:Pain / Q000188:drug therapy*; D011736:Pyridoxine / Q000627:therapeutic use*; D011804:Quinolines / Q000627:therapeutic use*; D012216:Rheumatic Diseases / Q000188:drug therapy*; D014805:Vitamin B 12 / Q000627:therapeutic use*
D000700:Analgesics; D011804:Quinolines; D000632:Aminopyrine; D011736:Pyridoxine; D014805:Vitamin B 12
Sperimentazione clinica dell'associazione: ortossichinolinsulfonato di aminofenazone-vitamina B 6- vitamin B 12 (Liocausyth) nelle malattie reumatologiche e neuritiche.